First Trust Nasdaq Pharmaceuticals ETF Rating $28.22 +0.27 (+0.95%) Closing price 09/5/2025 03:31 PM EasternExtended Trading$28.22 0.00 (0.00%) As of 09/5/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock First Trust Nasdaq Pharmaceuticals ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.FTXH Aggregate RatingModerate Buy 2.52Holdings in FTXH have an aggregate rating of Moderate Buy based on 441 analyst ratings issued in the past year covering 25 companies (86.9% of the portfolio).FTXH Aggregate Price Target$28.23High Prediction$28.23Average Prediction$28.23Low Prediction$28.23Holdings in FTXH have an aggregate price target of $28.23 and a range of $28.23 to $28.23 covering 25 companies (86.9% of the portfolio).FTXH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy1 Buy rating(s)Moderate Buy14 Moderate Buy rating(s)Hold8 Hold rating(s)Reduce2 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by First Trust Nasdaq Pharmaceuticals ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 FTXH Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings8.09%JNJJohnson & Johnson$178.20-0.3%4.6023 of 5 stars2.65$176.29 -1.1%20Trending NewsAnalyst DowngradeInsider Trade7.50%ABBVAbbVie$212.34-0.3%4.6364 of 5 stars2.92$214.95 1.2%26Trending NewsDividend Announcement7.29%PFEPfizer$24.86+1.3%4.8959 of 5 stars2.39$28.12 13.1%18Trending News7.05%MRKMerck & Co., Inc.$84.59+0.6%4.9971 of 5 stars2.35$107.44 27.0%20Positive News5.98%BMYBristol Myers Squibb$47.08+0.8%4.883 of 5 stars2.24$56.38 19.7%21Positive NewsInsider TradeAnalyst Revision4.29%VTRSViatris$10.50+1.6%1.6787 of 5 stars1.80$10.40 -1.0%53.74%GILDGilead Sciences$115.05+2.0%4.9667 of 5 stars2.88$115.39 0.3%26Positive News3.69%BIIBBiogen$140.67+0.5%4.7723 of 5 stars2.34$185.74 32.0%32Trending NewsAnalyst Forecast3.63%UTHRUnited Therapeutics$400.52+5.3%4.4733 of 5 stars2.69$429.62 7.3%13Trending NewsAnalyst ForecastInsider TradeShort Interest ↑Analyst Revision3.55%AMGNAmgen$283.64+1.3%4.734 of 5 stars2.32$304.43 7.3%22Positive NewsAnalyst Forecast3.49%ZTSZoetis$153.150.0%4.8489 of 5 stars2.50$202.43 32.2%8Positive News3.19%JAZZJazz Pharmaceuticals$129.50+1.2%4.5922 of 5 stars2.88$178.67 38.0%16Positive NewsInsider Trade3.14%REGNRegeneron Pharmaceuticals$573.38+1.1%4.7318 of 5 stars2.82$817.67 42.6%28Positive NewsAnalyst Upgrade2.88%LLYEli Lilly and Company$726.35-2.2%5 of 5 stars2.70$950.17 30.8%23Trending News2.73%ELANElanco Animal Health$18.40+5.3%2.9521 of 5 stars2.78$17.33 -5.8%9Analyst Revision2.62%MEDPMedpace$486.98+1.0%4.3747 of 5 stars1.94$412.73 -15.2%16News CoverageAnalyst DowngradeInsider Trade2.09%CRLCharles River Laboratories International$164.00+1.0%4.0661 of 5 stars2.27$175.69 7.1%15Short Interest ↑1.98%ILMNIllumina$98.93+1.3%4.8814 of 5 stars2.21$123.06 24.4%19Positive NewsAnalyst Forecast1.96%EXELExelixis$37.88+1.3%4.818 of 5 stars2.52$44.06 16.3%231.70%OGNOrganon & Co.$10.37+7.1%4.776 of 5 stars2.80$17.33 67.2%5News CoveragePositive News1.70%HALOHalozyme Therapeutics$74.93+2.1%4.58 of 5 stars2.33$67.11 -10.4%12Trending NewsAnalyst UpgradeInsider TradeAnalyst Revision1.59%NBIXNeurocrine Biosciences$144.10+2.6%4.7695 of 5 stars2.86$160.00 11.0%21Positive NewsAnalyst ForecastShort Interest ↑1.07%BMRNBioMarin Pharmaceutical$57.77+1.8%4.9877 of 5 stars2.72$93.43 61.7%25News CoveragePositive NewsAnalyst Forecast0.99%ALKSAlkermes$29.94+3.5%4.7479 of 5 stars2.92$41.31 38.0%13News CoveragePositive NewsAnalyst Forecast0.95%AMRXAMNEAL PHARMACEUTICALS$9.62+0.7%3.4801 of 5 stars3.00$11.60 20.6%5News CoveragePositive News This page (NASDAQ:FTXH) was last updated on 9/6/2025 by MarketBeat.com Staff From Our PartnersScientists Discover Untapped Energy Source in Heart of USACrash Coming Sept 30? Analysts Warn of New Crisis A new problem on the U.S. power grid is putting millions ...Altimetry | Sponsored6-Figure Target for BTC by 2025The U.S. just announced it's putting GDP data directly onto Bitcoin and Ethereum blockchains. Could this spa...Crypto 101 Media | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored3 Major A.I. Threats That Could Upend the U.S. EconomyThe media's calling Artificial Intelligence a "revolution," but for many Americans, the real impact might actu...Goldco Precious Metals | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | Sponsored“HELIOS”: My No. 1 Investment of the 2020sA mysterious new energy technology — backed by Nvidia, Google, and even legendary investors like Stanley Druck...Stansberry Research | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding First Trust Nasdaq Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share First Trust Nasdaq Pharmaceuticals ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
